The 2022 ACR vaccination guideline: a call-to-action

Among the limited quality and quantity of evidence on vaccination use in individuals with rheumatic and musculoskeletal diseases, a new guideline, developed with a rigorous methodology, provides useful support to clinicians and patients in making health-related decisions. Most recommendations are co...

Descripción completa

Detalles Bibliográficos
Autores principales: Colmegna, Inés, Libman, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042393/
https://www.ncbi.nlm.nih.gov/pubmed/36973498
http://dx.doi.org/10.1038/s41584-023-00954-0
_version_ 1784912925024059392
author Colmegna, Inés
Libman, Michael
author_facet Colmegna, Inés
Libman, Michael
author_sort Colmegna, Inés
collection PubMed
description Among the limited quality and quantity of evidence on vaccination use in individuals with rheumatic and musculoskeletal diseases, a new guideline, developed with a rigorous methodology, provides useful support to clinicians and patients in making health-related decisions. Most recommendations are conditional, serving as a call to action for further research.
format Online
Article
Text
id pubmed-10042393
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100423932023-03-28 The 2022 ACR vaccination guideline: a call-to-action Colmegna, Inés Libman, Michael Nat Rev Rheumatol News & Views Among the limited quality and quantity of evidence on vaccination use in individuals with rheumatic and musculoskeletal diseases, a new guideline, developed with a rigorous methodology, provides useful support to clinicians and patients in making health-related decisions. Most recommendations are conditional, serving as a call to action for further research. Nature Publishing Group UK 2023-03-27 2023 /pmc/articles/PMC10042393/ /pubmed/36973498 http://dx.doi.org/10.1038/s41584-023-00954-0 Text en © Springer Nature Limited 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News & Views
Colmegna, Inés
Libman, Michael
The 2022 ACR vaccination guideline: a call-to-action
title The 2022 ACR vaccination guideline: a call-to-action
title_full The 2022 ACR vaccination guideline: a call-to-action
title_fullStr The 2022 ACR vaccination guideline: a call-to-action
title_full_unstemmed The 2022 ACR vaccination guideline: a call-to-action
title_short The 2022 ACR vaccination guideline: a call-to-action
title_sort 2022 acr vaccination guideline: a call-to-action
topic News & Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042393/
https://www.ncbi.nlm.nih.gov/pubmed/36973498
http://dx.doi.org/10.1038/s41584-023-00954-0
work_keys_str_mv AT colmegnaines the2022acrvaccinationguidelineacalltoaction
AT libmanmichael the2022acrvaccinationguidelineacalltoaction
AT colmegnaines 2022acrvaccinationguidelineacalltoaction
AT libmanmichael 2022acrvaccinationguidelineacalltoaction

Ejemplares similares